Table 2.

Splenic IL-4 ELISPOT assay in mice receiving BM transplant with anti-CD8, anti-CD40L, and 3 Gy TBI



Day 4

Day 8

Day 15

Day 36

B6
B10.A
3rd party
B6
B10.A
3rd party
B6
B10.A
3rd party
B6
B10.A
3rd party
nl B6   22   252   291   0   254   309   30   217   235   40   460   433  
Conditioned control (no BMT)   0   22   88   5   168   136   3   123   203   20   213   208  
BMT with no MR1   202   188   205   0   563   78   0   416   240   0   411   211  
Chimera 1   268   101   314   53   13   208   35   82   380   0   0   313  
Chimera 2   143   0   295   25   78   240   15   0   160   0   0   193  
Chimera 3
 
137
 
0
 
363
 
0
 
81
 
176
 
ND
 
ND
 
ND
 
3
 
23
 
225
 


Day 4

Day 8

Day 15

Day 36

B6
B10.A
3rd party
B6
B10.A
3rd party
B6
B10.A
3rd party
B6
B10.A
3rd party
nl B6   22   252   291   0   254   309   30   217   235   40   460   433  
Conditioned control (no BMT)   0   22   88   5   168   136   3   123   203   20   213   208  
BMT with no MR1   202   188   205   0   563   78   0   416   240   0   411   211  
Chimera 1   268   101   314   53   13   208   35   82   380   0   0   313  
Chimera 2   143   0   295   25   78   240   15   0   160   0   0   193  
Chimera 3
 
137
 
0
 
363
 
0
 
81
 
176
 
ND
 
ND
 
ND
 
3
 
23
 
225
 

Each value represents the mean number of spots (2 wells) obtained with 1 × 106 initial splenocytes. Chimeras received 3 Gy TBI, anti-CD8 mAb, MR1, and BMT; conditioned controls received TBI, anti-CD8, MR1; BMT with no MR1 received TBI, anti-CD8, and BMT. ND indicates not done.

or Create an Account

Close Modal
Close Modal